Search
for
Sort by
Research 61–90 of 88
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Androgenetic alopecia, hirsutism and hypertrichosis
- Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Pharmacological basis for clinical use of antiandrogens
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- Adult female acne: a guide to clinical practice
- Progestogens with Antiandrogenic Properties
- Female pattern alopecia: current perspectives
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Menopausal Acne – Challenges And Solutions
- Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Functional characterization and unraveling the structural determinants of novel steroid hydroxylase CYP154C7 from Streptomyces sp. PAMC26508
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- Drugs and Androgenetic Alopecia: What to look out for
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Acne Vulgaris
- Female pattern hair loss: therapeutic update
- Diseases of the Canine Prostate Gland
- Hormone und Behaarung
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis